Atorka has acqired 20% stake in Shanghai Century Acquisition Corp or SHA which is listed on the AMEX stock marked in New York. The buy took place over the past weeks and the total price of Atorka´s stake is approximately ISK 2 billion. Atorka financed the purchase with cash. SHA is a Special Purpose Acquisition Corporation (SPAC) and has currently negotiated the buy of the Chinese pharmaceutical company Sichuan Kelun Pharmaceutical or Kelun, provisionally pending approval from the Chinese Competition and Fair Trade Authority which is an ongoing process. Kelun is a leading corporation in manufacturing and distribution of IV solutions in China. They operate 13 manufacturing facilities in China along with 53 sales offices and the total number of employees is approximately 6.800. Kelun produces about 90 different kinds of IV solutions and their total production capacity is approximately 1, 4 billion doses a year. The corporation also manufactures hypodermic medication and OTC. There is a foreseeable growth in the healthcare industry in China in coming years for which Kelun has a strategic advantage for. In the past few months Atorka has acquired warrants in the corporation that will be applied when the Kelun acquisition goes through. About Atorka Group Atorka Group is an investment company listed on the OMX Nordic Exchange in Iceland. Atorka supports progressive enterprises that take advantage of worldwide developments, assisting those companies in becoming global leaders.In its investments, Atorka seeks out companies that have sound operation and strong management and possess the potential for substantial internal and external growth. The Company targets projects with considerable potential for growth and value enhancement, aiming at investments for periods of 3-5 years. For further information, contact Magnús Jónsson, CEO of Atorka (tel. +354 840 6240) and Valdis Arnardottir PR and Communication Manager (tel. + 354 840 6217)